320 related articles for article (PubMed ID: 32381104)
1. Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
Fang W; Che X; Li G; Wang A; Wang Y; Shi X; Hou K; Zhang X; Qu X; Liu Y
J Exp Clin Cancer Res; 2020 May; 39(1):82. PubMed ID: 32381104
[TBL] [Abstract][Full Text] [Related]
2. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.
Fei B; Chi AL; Weng Y
World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525
[TBL] [Abstract][Full Text] [Related]
3. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of survivin by Granzyme M triggers degradation of the survivin-X-linked inhibitor of apoptosis protein (XIAP) complex to free caspase activity leading to cytolysis of target tumor cells.
Hu D; Liu S; Shi L; Li C; Wu L; Fan Z
J Biol Chem; 2010 Jun; 285(24):18326-35. PubMed ID: 20406824
[TBL] [Abstract][Full Text] [Related]
5. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer.
Hagenbuchner J; Oberacher H; Arnhard K; Kiechl-Kohlendorfer U; Ausserlechner MJ
Theranostics; 2019; 9(17):4909-4922. PubMed ID: 31410190
[TBL] [Abstract][Full Text] [Related]
7. Double targeting of Survivin and XIAP radiosensitizes 3D grown human colorectal tumor cells and decreases migration.
Hehlgans S; Petraki C; Reichert S; Cordes N; Rödel C; Rödel F
Radiother Oncol; 2013 Jul; 108(1):32-9. PubMed ID: 23830189
[TBL] [Abstract][Full Text] [Related]
8. A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-κB activation and apoptosis in P19 cells.
Rochira JA; Matluk NN; Adams TL; Karaczyn AA; Oxburgh L; Hess ST; Verdi JM
PLoS One; 2011; 6(7):e20659. PubMed ID: 21789165
[TBL] [Abstract][Full Text] [Related]
9. NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo.
Ma Q; Gu L; Liao S; Zheng Y; Zhang S; Cao Y; Zhang J; Wang Y
Apoptosis; 2019 Feb; 24(1-2):83-94. PubMed ID: 30515612
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
Qiao L; Dai Y; Gu Q; Chan KW; Zou B; Ma J; Wang J; Lan HY; Wong BC
Mol Cancer Ther; 2008 Jul; 7(7):2203-11. PubMed ID: 18645029
[TBL] [Abstract][Full Text] [Related]
11. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
[TBL] [Abstract][Full Text] [Related]
12. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer.
Agarwal E; Chaudhuri A; Leiphrakpam PD; Haferbier KL; Brattain MG; Chowdhury S
BMC Cancer; 2014 Mar; 14():145. PubMed ID: 24581231
[TBL] [Abstract][Full Text] [Related]
13. Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma.
Werner TA; Dizdar L; Nolten I; Riemer JC; Mersch S; Schütte SC; Driemel C; Verde PE; Raba K; Topp SA; Schott M; Knoefel WT; Krieg A
Sci Rep; 2017 Sep; 7(1):11383. PubMed ID: 28900184
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid potentiated oxaliplatin to induce apoptosis in colorectal cancer RKO cells.
Zheng J-; Wang SS; Shen KP; Huang XW; Li M; Chen L; Peng X; An HM; Hu B
Pharmazie; 2020 Jun; 75(6):246-249. PubMed ID: 32539919
[TBL] [Abstract][Full Text] [Related]
16. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
18. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
[TBL] [Abstract][Full Text] [Related]
19. Ezrin expression and cell survival regulation in colorectal cancer.
Leiphrakpam PD; Rajput A; Mathiesen M; Agarwal E; Lazenby AJ; Are C; Brattain MG; Chowdhury S
Cell Signal; 2014 May; 26(5):868-79. PubMed ID: 24462708
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201.
Huerta S; Gao X; Livingston EH; Kapur P; Sun H; Anthony T
Surgery; 2010 Aug; 148(2):346-53. PubMed ID: 20633731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]